Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

425
The pathophysiology of pneumonia involves the following steps:
425
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

18
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
18
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

17
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
17
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

247
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
247
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

353
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
353

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Full Technical Report: Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba.

MEDICC review·2022
Same journal

Executive Summary: Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba.

MEDICC review·2022
Same journal

A Shift in SARS-CoV-2 Omicron Variant's Entry Pathway Might Explain Different Clinical Outcomes.

MEDICC review·2022
Same journal

Families in Grief: Need for Psychological Care and Support for Those Who Lost Loved Ones to COVID-19.

MEDICC review·2022
Same journal

High Levels of Serum Bile Acids in COVID-19 Patients on Hospital Admission.

MEDICC review·2022
Same journal

Effect of Cuban Porcine Pulmonary Surfactant (Surfacen) and rCmPI-II Protease Inhibitor on Neutrophil Elastase Activity.

MEDICC review·2022
See all related articles

Related Experiment Video

Updated: Aug 20, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.1K

Polyserositis as a Post-Covid-19 Complication.

Julio C Hernández-Perera1, Dania Piñeiro-Pérez1, Juan O Martínez-Muñiz1

  • 1Medical-Surgical Research Center (CIMEQ), Havana, Cuba.

MEDICC Review
|November 23, 2022
PubMed
Summary
This summary is machine-generated.

This case study reports a rare instance of polyserositis, a condition affecting multiple serous membranes, occurring as a late complication four months after COVID-19 infection. This finding highlights a potential long-term consequence of the virus.

Keywords:
COVID-19CubaSARS-CoV-2colchicinepericardial effusionpericarditispleural effusionthoracoscopy

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

524
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.3K

Related Experiment Videos

Last Updated: Aug 20, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.1K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

524
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.3K

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Pulmonology

Background:

  • Polyserositis involves inflammation and fluid accumulation in multiple serous membranes.
  • Published literature on polyserositis as a late complication of COVID-19 is scarce.
  • This study aims to document a unique case of post-COVID-19 polyserositis.

Observation:

  • A 57-year-old female presented with syncope and weakness four months post-COVID-19.
  • She had a history of obesity, type 2 diabetes, and asthma.
  • Clinical evaluation revealed pericardial and bilateral pleural effusions, along with a lesion near the right ventricle.

Findings:

  • Diagnostic workup, including imaging and surgical exploration, identified thymic remnants and polyserositis.
  • Other potential causes of polyserositis were systematically excluded.
  • The polyserositis was attributed as a late complication of COVID-19 due to a probable pathogenic link.

Implications:

  • This case represents the second reported instance globally and the first in Cuba of polyserositis following COVID-19.
  • It underscores the potential for diverse and delayed post-viral sequelae.
  • Further research is warranted to understand the mechanisms and prevalence of such late COVID-19 complications.